Clinical Trial Update: Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients

View source ↗

Summary

This clinical trial aims to integrate tumor genomics and urinary exosomal proteomics to develop a multi-layer biomarker framework for early risk stratification …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Genomics, Thyroid Cancer | Status: NOT_YET_RECRUITING